Healthcare provider profile · identity verified

Parimala Dommeti, M.D.

Geriatric Medicine · DEARBORN, MI · NPI 1801938162

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	504	164
Levothyroxine Sodium	Levothyroxine Sodium	351	107
Gabapentin	Gabapentin	317	62
Omeprazole	Omeprazole	303	91
Losartan Potassium	Losartan Potassium	274	84
Amlodipine Besylate	Amlodipine Besylate	252	85
Furosemide	Furosemide	247	75
Lisinopril	Lisinopril	238	69
Metformin Hcl	Metformin Hcl	238	52
Donepezil Hcl	Donepezil Hcl	195	52
Simvastatin	Simvastatin	195	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	194	33
Metoprolol Tartrate	Metoprolol Tartrate	191	53
Pantoprazole Sodium	Pantoprazole Sodium	165	47
Eliquis	Apixaban	159	43
Metoprolol Succinate	Metoprolol Succinate	158	51
Hydralazine Hcl	Hydralazine Hcl	138	34
Alendronate Sodium	Alendronate Sodium	128	35
Sertraline Hcl	Sertraline Hcl	126	34
Escitalopram Oxalate	Escitalopram Oxalate	123	40
Alprazolam	Alprazolam	121	19
Tamsulosin Hcl	Tamsulosin Hcl	120	34
Citalopram Hbr	Citalopram Hydrobromide	114	22
Tramadol Hcl	Tramadol Hcl	111	32
Clopidogrel	Clopidogrel Bisulfate	110	35
Duloxetine Hcl	Duloxetine Hcl	104	26
Potassium Chloride	Potassium Chloride	91	33
Carvedilol	Carvedilol	90	27
Mirtazapine	Mirtazapine	86	23
Quetiapine Fumarate	Quetiapine Fumarate	85	17
Albuterol Sulfate Hfa	Albuterol Sulfate	83	34
Hydrochlorothiazide	Hydrochlorothiazide	79	28
Montelukast Sodium	Montelukast Sodium	77	19
Rosuvastatin Calcium	Rosuvastatin Calcium	77	24
Famotidine	Famotidine	71	21
Glipizide	Glipizide	67	18
Januvia	Sitagliptin Phosphate	65	suppressed
Trazodone Hcl	Trazodone Hcl	60	13
Prednisone	Prednisone	58	27
Atenolol	Atenolol	55	18
Bupropion Xl	Bupropion Hcl	55	suppressed
Fluticasone Propionate	Fluticasone Propionate	54	25
Memantine Hcl	Memantine Hcl	54	13
Finasteride	Finasteride	51	14
Cephalexin	Cephalexin	50	39
Xarelto	Rivaroxaban	47	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	46	11
Lactulose	Lactulose	44	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Calcitriol	Calcitriol	41	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	11
Methocarbamol	Methocarbamol	41	13
Ozempic	Semaglutide	41	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	15
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Pregabalin	Pregabalin	39	14
Nystatin	Nystatin	38	20
Allopurinol	Allopurinol	35	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Meclizine Hcl	Meclizine Hcl	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	12
Jardiance	Empagliflozin	31	13
Azithromycin	Azithromycin	30	26
Digoxin	Digoxin	30	suppressed
Ibandronate Sodium	Ibandronate Sodium	30	suppressed
Latanoprost	Latanoprost	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	19
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	11
Lorazepam	Lorazepam	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	14
Baclofen	Baclofen	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Folic Acid	Folic Acid	22	suppressed
Lacosamide	Lacosamide	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Bumetanide	Bumetanide	20	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Valsartan	Valsartan	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Atrovent Hfa	Ipratropium Bromide	15	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Mirabegron Er	Mirabegron	12	suppressed
Ondansetron Odt	Ondansetron	12	12
Risperidone	Risperidone	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Nystop	Nystatin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error